Science Explorer Back to mapMap
Discussion
Topic · Ophthalmology

Ocular Diseases and Behçet’s Syndrome

Ocular Diseases and Behçet’s Syndrome is a research topic within Ophthalmology. Science Explorer counts 30k research works in it since 1950. 10.1% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the epidemiology, diagnosis, and management of ocular inflammatory diseases, particularly uveitis and Behçet's disease. It covers topics such as the use of immunosuppressive drugs, anti-TNF therapy, and interferon alpha2a therapy in the treatment of these conditions. Additionally, it discusses the epidemiological patterns and prevalence of ocular inflammatory diseases, including their association with juvenile idiopathic arthritis.

  • Uveitis
  • Behçet's Disease
  • Vogt-Koyanagi-Harada Disease
  • Inflammatory Eye Diseases
  • Immunosuppressive Therapy
  • Anti-TNF Therapy
  • Juvenile Idiopathic Arthritis
  • Epidemiology
  • Interferon Alpha2a Therapy
  • Choroiditis
Research works
30k
fractional, since 1950
In the world top 10%
3k
per year above
Top-10% rate
10.1%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+5%
the tick is no change
Largest producer
United States
26% of the 10 largest, 2022-now
Ocular Diseases and Behçet’s Syndrome

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Ocular Diseases and Behçet’s Syndrome research?

By volume, the United States and China publish the most (1.2k and 970 works in 2022-now).

By volume, 2022-now

  1. 1 United States 1.2k works
  2. 2 China 970 works
  3. 3 India 652 works
  4. 4 Türkiye 361 works
  5. 5 Japan 294 works
  6. 6 United Kingdom 268 works
  7. 7 Italy 227 works
  8. 8 Spain 202 works
  9. 9 France 195 works
  10. 10 South Korea 184 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 26.4%China: 21.3%India: 14.3%Türkiye: 7.9%6 others listed: 30.1%26%largest
United States1,202 · 26.4%China970 · 21.3%India652 · 14.3%Türkiye361 · 7.9%6 others listed1,369 · 30.1%

Shares of the rows listed above, not of the whole node.

Which institutions lead Ocular Diseases and Behçet’s Syndrome research?

By volume in 2022-now, Harvard University publishes the most Ocular Diseases and Behçet’s Syndrome research, followed by All India Institute of Medical Sciences and L V Prasad Eye Institute.

By volume, 2022-now

  1. 1 Harvard UniversityUnited States 61 works
  2. 2 All India Institute of Medical SciencesIndia 60 works
  3. 3 L V Prasad Eye InstituteIndia 53 works
  4. 4 Sankara NethralayaIndia 49 works
  5. 5 Capital Medical UniversityChina 47 works
  6. 6 Sun Yat-sen UniversityChina 45 works
  7. 7 University College LondonUnited Kingdom 41 works
  8. 8 Aravind Eye HospitalIndia 40 works
  9. 9 Chongqing Medical UniversityChina 33 works
  10. 10 Johns Hopkins UniversityUnited States 33 works

Who are the leading researchers in Ocular Diseases and Behçet’s Syndrome?

The most-cited researchers publishing on Ocular Diseases and Behçet’s Syndrome include Mark J. Daly, Jost Bruno Jonas and Shizuo Akira.

  1. 1 Mark J. Daly United States 403k citations
  2. 2 Jost Bruno Jonas Germany 350k citations
  3. 3 Shizuo Akira Japan 342k citations
  4. 4 Jun Wang China 340k citations
  5. 5 Graeme J. Hankey Australia 316k citations
  6. 6 Jeremy Grimshaw Canada 281k citations
  7. 7 Jasvinder A. Singh United States 247k citations
  8. 8 André Gerardus Uitterlinden Netherlands 246k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Ocular Diseases and Behçet’s Syndrome?

The most cited paper in Ocular Diseases and Behçet’s Syndrome is "Ranibizumab for Neovascular Age-Related Macular Degeneration" (Philip J. Rosenfeld, David M. Brown, Jeffrey S. Heier et al., 2006), with 5,931 citations. Next come "Standardization of Uveitis Nomenclature for Reporting Clinical Data. Results of the First International Workshop" (4,424) and "Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration" (2,681).

Most cited papers
#PaperReleasedCitations
1 Ranibizumab for Neovascular Age-Related Macular Degeneration Philip J. Rosenfeld, David M. Brown, Jeffrey S. Heier et al. · New England Journal of Medicine Open access 4 Oct 2006 5,931
2 Standardization of Uveitis Nomenclature for Reporting Clinical Data. Results of the First International Workshop Douglas A. Jabs, Robert Burton Nussenblatt, James Todd Rosenbaum · American Journal of Ophthalmology Open access 19 Jul 2005 4,424
3 Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration The CATT Research Group · New England Journal of Medicine Open access 28 Apr 2011 2,681
4 Revised diagnostic criteria for neuromyelitis optica Dean M. Wingerchuk, Vanda A. Lennon, Sean Joseph Pittock et al. · Neurology Open access May 2006 2,585
5 Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration Jonathan L. Haines, Michael A. Hauser, Silke Schmidt et al. · Science 10 Mar 2005 2,436
All 99 most cited papers, with filters and sorting

Where is Ocular Diseases and Behçet’s Syndrome research done?

The largest centres of Ocular Diseases and Behçet’s Syndrome research in 2022-now are Beijing (China), Istanbul (Türkiye), Seoul (South Korea) and London (United Kingdom). Among places with at least 20 works in it, it is an unusually large share of all research in Madurai.

Largest cities, 2022-now

  1. 1 BeijingChina 163 works
  2. 2 IstanbulTürkiye 129 works
  3. 3 SeoulSouth Korea 101 works
  4. 4 LondonUnited Kingdom 101 works
  5. 5 ParisFrance 88 works
  6. 6 ShanghaiChina 85 works
  7. 7 ChennaiIndia 81 works
  8. 8 GuangzhouChina 78 works
  9. 9 TokyoJapan 72 works
  10. 10 AnkaraTürkiye 68 works

Where it is the local speciality

  1. MaduraiIN · 41.3 works23×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Ocular Diseases and Behçet’s Syndrome than the world average.

See Ocular Diseases and Behçet’s Syndrome on the map

Where is the best place to study Ocular Diseases and Behçet’s Syndrome?

Among universities, judged by research, Harvard University, Chongqing Medical University and Wenzhou Medical University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%30%mean 17.11%fractional works in this field (log) →share of work in the world top 10% →Chongqing Medical Un…Wenzhou Medical Univ…Case Western Reserve…Harvard University
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Harvard UniversityUnited States 77.417.2%3.3×61 +3.2%
2Chongqing Medical UniversityChina 70.925.6%10.0×33 -12.7%
3Wenzhou Medical UniversityChina 70.521.1%8.6×26 +53.4%
4Case Western Reserve UniversityUnited States 67.119.4%6.0×21 +45.7%
5University College LondonUnited Kingdom 66.416.5%4.3×41 -28.2%
6Sun Yat-sen UniversityChina 64.816.1%3.7×45 +6.9%
7Johns Hopkins UniversityUnited States 64.812.3%3.6×33 -12.5%
8Istanbul University-CerrahpaşaTürkiye 63.514.1%18.7×26 -4.0%
9Vita-Salute San Raffaele UniversityItaly 63.116.8%15.9×12 +40.9%
10University of MiamiUnited States 62.712.0%8.0×29 -5.9%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Ocular Diseases and Behçet’s Syndrome, country by country

Is Ocular Diseases and Behçet’s Syndrome research growing?

Output in 2022-2025 was 5% higher than in 2018-2021, peaking in 2022. The fastest-growing topics are Ocular Diseases and Behçet’s Syndrome.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Ocular Diseases and Behçet’s Syndrome as a percentage of every work published that year, 0.024% in 2024.

still counting0.020%0.040%Ocular Diseases and Behçet’s Syndrome0.026% in 202519801990200020102020

Fractional works of Ocular Diseases and Behçet’s Syndrome over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Ocular Diseases and Behçet’s Syndrome10.1% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Ocular Diseases and Behçet’s Syndrome. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.